Skip to main content

Table 1 Schedule of visits and assessments

From: Quetiapine augmentation of prolonged exposure therapy in veterans with PTSD and a history of mild traumatic brain injury: design and methodology of a pilot study

Assessments

V0

V1

V2

V3

V4

V5

V6

V7

V8

V9

V10

V11

Scr

WK1

WK3

WK4

WK5

WK6

WK7

WK8

WK9

WK10

WK11

WK12

Informed consent

X

           

Med history & physical exam

X

           

CAPS-5

X

          

X

PCL-5

X

X

X

X

X

X

X

X

X

X

X

X

PSQI

X

X

X

X

X

X

X

X

X

X

X

X

PHQ-9

X

X

X

X

X

X

X

X

X

X

X

X

QOLS

X

          

X

WHODAS 2.0

X

          

X

PTGI

X

          

X

Medication diary

X

X

X

X

X

X

X

X

X

X

X

X

Medication dosing

 

X

X

X

X

X

X

X

X

X

X

X

Medication adjustment

 

X

X

 

X

   

X

  

X

Adverse effects

  

X

X

X

X

X

X

X

X

X

X

Psychotherapy

  

S1

S2

S3

S4

S5

S6

S7

S8

S9

S10

Self-report of engagement

  

X

X

X

X

X

X

X

X

X

X

Vital signs

X

X

X

X

X

X

X

X

X

X

X

X

Labs

X

          

X

ECG

X

          

X

  1. Shown are procedures completed at visits (V#) / weeks (WK) of study. Screening (Scr) occurs at V0 and medication reduction or initiation occurs from Weeks 1–3
  2. Abbreviations: CAPS-5 Clinician-Administered PTSD Scale for DSM-5, PCL-5 PTSD Checklist for DSM-5, PSQI Pittsburgh Sleep Quality Index, WHODAS 2.0 World Health Organization Disability Assessment Schedule 2.0, QOLS Quality of Life Scale, PHQ-9 Patient Health Questionnaire, PTGI Post Traumatic Growth Inventory, ECG 12-lead electrocardiogram